Form 8-K - Current report:
SEC Accession No. 0001628280-26-047590
Filing Date
2026-07-08
Accepted
2026-07-08 08:02:02
Documents
11
Period of Report
2026-07-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K prme-20260706.htm   iXBRL 8-K 23153
  Complete submission text file 0001628280-26-047590.txt   140625

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prme-20260706.xsd EX-101.SCH 1800
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prme-20260706_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prme-20260706_pre.xml EX-101.PRE 13055
14 EXTRACTED XBRL INSTANCE DOCUMENT prme-20260706_htm.xml XML 2913
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41536 | Film No.: 261160797
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)